Skip to content
Peptigraph home

5-Amino-1MQ Benefits: Claims vs What Studies Show

Benefits people claim for 5-Amino-1MQ, set against what published studies measured, and where no study exists.

Medical review pendingNNMT inhibitor (not a peptide)Updated
Strongest evidence
Animal
Human / animal studies
0 / 1
in our evidence file (PubMed search, 11 Oct 2026)
FDA status
Not approved
research chemical

Claimed benefits and what studies show

Each row is an area where people claim a benefit, with the strongest study we summarise behind it. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

5-Amino-1MQ claimed benefits and the studies behind them
ClaimBest evidenceStudies (human / animal)What was measuredPage
MetabolismAnimal evidence, 2 of 40 / 2Adiposity and weight loss with low-fat diet; NNMT inhibition by quinolinium scaffoldEvidence for metabolism
Weight lossAnimal evidence, 2 of 40 / 1Adiposity and weight loss with low-fat dietEvidence for weight loss

Strongest study per claim: Metabolism, Scientific reports 2022, PMID 35013352; Weight loss, Scientific reports 2022, PMID 35013352.

What the studies measured

5-Amino-1MQ outcomes in published studies
OutcomeResultStudy typeSource
Adiposity and weight loss with low-fat dietIn diet-induced obese mice, 5-amino-1-methylquinolinium combined with a low-fat diet promoted marked loss of adiposity and weight, normalising them to lean animals, which the diet switch alone did not do.Animal · mouse (not a human result)Scientific reports 2022, PMID 35013352
Cancer cell viabilityNNMT inhibitors reduced viability, increased reactive oxygen species and activated apoptosis in osteosarcoma and Merkel cell carcinoma cells in culture.In vitro (not a human result)Biomolecules 2025, PMID 41301471
Cell proliferation5MQ inhibited HeLa cervical cancer cell proliferation without apparently affecting HEK-293 cells in culture.In vitro (not a human result)Journal of obstetrics and gynaecology 2021, PMID 33645410
NNMT inhibition by quinolinium scaffoldQuinolinium analogues were identified as a promising NNMT-inhibitor scaffold with IC50 of about 1 μM in enzyme assays.In vitro (not a human result)Journal of medicinal chemistry 2017, PMID 28548833
Not shown in any study we cite. Searches behind this page: PubMed search on 2 Oct 2026 for “"5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab]”: 3 results. PubMed search on 2 Oct 2026 for “nicotinamide N-methyltransferase[tiab] AND (quinolinium[tiab] OR 5-amino-1MQ[tiab] OR "5-amino-1-methylquinolinium"[tiab] OR 5MQ[tiab])”: 6 results. PubMed search on 11 Oct 2026 for “("5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt])”: 0 results.

Fat loss and metabolism: what was actually tested

The weight and fat-loss claim traces to a mouse study: in diet-induced obese mice, 5-amino-1MQ plus a low-fat diet was reported to produce marked fat and weight loss. This is animal data.[1]

In that mouse work, switching to a low-fat diet alone did not bring the animals' body measures back to those of lean controls over the same period.[1]

The same paper reports a distinct gut-bacteria pattern in the treated mice, which the authors tied to body weight and metabolic regulation (again in mice).[1]

What the lab studies add

Enzyme studies found quinolinium compounds to be a promising scaffold for blocking the enzyme NNMT, with potency in the low micromolar range, which is test-tube work.[4]

In human cervical cancer cells in a dish, 5MQ slowed proliferation, a cancer-cell result that says nothing about weight.[3]

In human osteosarcoma and Merkel cell carcinoma cell lines, NNMT inhibitors including 5-amino-1MQ lowered cell viability, which is again cell data.[2]

What no study has shown

A dated PubMed search on 2026-10-02 for "5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab] found 3 results.

Calculated from query "5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab]; date 2026-10-02; result count 3. Formula: count reported by the search record in the evidence file

A dated PubMed search on 2026-10-11 for ("5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) found 0 results.

Calculated from query ("5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]); date 2026-10-11; result count 0. Formula: count reported by the search record in the evidence file

Common questions

Is 5-Amino-1MQ proven to work?

The strongest study we summarise for 5-Amino-1MQ is animal evidence, among 4 studies. That is not proof it works in people.

What does 5-amino-1MQ do?

In published work it blocks the enzyme NNMT; the body-weight result is from obese mice and the other results are from cultured cells.[1]

Is 5-amino-1MQ proven to work in people?

A dated PubMed search on 2026-10-02 for nicotinamide N-methyltransferase[tiab] AND (quinolinium[tiab] OR 5-amino-1MQ[tiab] OR "5-amino-1-methylquinolinium"[tiab] OR 5MQ[tiab]) found 6 results.

Calculated from query nicotinamide N-methyltransferase[tiab] AND (quinolinium[tiab] OR 5-amino-1MQ[tiab] OR "5-amino-1-methylquinolinium"[tiab] OR 5MQ[tiab]); date 2026-10-02; result count 6. Formula: count reported by the search record in the evidence file

More on 5-Amino-1MQ

Sources

  1. 1Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice.Scientific reports · 2022PMID 35013352Accessed 2 Oct 2026
  2. 2Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy.Biomolecules · 2025PMID 41301471Accessed 2 Oct 2026
  3. 3Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2021PMID 33645410Accessed 2 Oct 2026
  4. 4Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase.Journal of medicinal chemistry · 2017PMID 28548833Accessed 2 Oct 2026
  5. 5PubMed search: "5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab] (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: nicotinamide N-methyltransferase[tiab] AND (quinolinium[tiab] OR 5-amino-1MQ[tiab] OR "5-amino-1-methylquinolinium"[tiab] OR 5MQ[tiab]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: ("5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (0 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026

Found an error? Report a correction.